1. Home
  2. TVTX vs SPT Comparison

TVTX vs SPT Comparison

Compare TVTX & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SPT
  • Stock Information
  • Founded
  • TVTX 2008
  • SPT 2010
  • Country
  • TVTX United States
  • SPT United States
  • Employees
  • TVTX N/A
  • SPT N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SPT Computer Software: Prepackaged Software
  • Sector
  • TVTX Health Care
  • SPT Technology
  • Exchange
  • TVTX Nasdaq
  • SPT Nasdaq
  • Market Cap
  • TVTX 1.4B
  • SPT 1.1B
  • IPO Year
  • TVTX N/A
  • SPT 2019
  • Fundamental
  • Price
  • TVTX $16.48
  • SPT $19.19
  • Analyst Decision
  • TVTX Strong Buy
  • SPT Buy
  • Analyst Count
  • TVTX 16
  • SPT 13
  • Target Price
  • TVTX $33.33
  • SPT $31.69
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • SPT 578.1K
  • Earning Date
  • TVTX 07-31-2025
  • SPT 08-06-2025
  • Dividend Yield
  • TVTX N/A
  • SPT N/A
  • EPS Growth
  • TVTX N/A
  • SPT N/A
  • EPS
  • TVTX N/A
  • SPT N/A
  • Revenue
  • TVTX $273,533,000.00
  • SPT $418,413,000.00
  • Revenue This Year
  • TVTX $73.84
  • SPT $12.32
  • Revenue Next Year
  • TVTX $46.72
  • SPT $11.90
  • P/E Ratio
  • TVTX N/A
  • SPT N/A
  • Revenue Growth
  • TVTX 75.65
  • SPT 17.79
  • 52 Week Low
  • TVTX $7.93
  • SPT $18.52
  • 52 Week High
  • TVTX $25.29
  • SPT $39.75
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.73
  • SPT 34.79
  • Support Level
  • TVTX $14.44
  • SPT $19.88
  • Resistance Level
  • TVTX $16.64
  • SPT $21.53
  • Average True Range (ATR)
  • TVTX 0.61
  • SPT 0.71
  • MACD
  • TVTX 0.31
  • SPT -0.06
  • Stochastic Oscillator
  • TVTX 94.18
  • SPT 3.17

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

Share on Social Networks: